The PSCI Fall Meeting 2025 took place for the first-time in China, marking a significant milestone for the PSCI.

Members from around the globe attended in-person (35) and virtually (80) at AstraZeneca in Shanghai to present on key projects, hear updates from the Board and Committees, and consider how the PSCI can deepen its support for the pharmaceutical industry in China. We were pleased to welcome one Supplier Partner in person, as well as meet with 6 prospective Supplier Partners all interested in learning more about collaboration.

Read below for highlights from the two-day event. Many thanks to all our Members, Partners, and Supplier Partners who presented and attended.

Day 1

• Tony Pusic, Senior Vice President Asia Pacific & International, AstraZeneca welcome attendees and shared the company’s own priorities for sustainability.
• Xuegong Wang, Vice President of CPEA, a long-standing partner of the PSCI in China, shared key trends and insights into the Chinese pharmaceutical market. CPEA is highly regarded industry association that brings together pharmaceutical companies to discuss policy, standards, best practices, and industry developments.
• A session hosted by the China Sub-team on how the PSCI can continue to support suppliers in China and build our brand as a value-creating organizations for the Chinese pharma and healthcare industry.
• Rincy Joseph and Dorota Wiacek, project leads for the Link 2.0 platform, presented our incoming digital platform, now being populated and launching for member use on Q1 2026. Watch this space for further announcements.
• Ranjana Ganguly, Aditya Shirodkar, and Rohit Virmani shared the successes of the PSCI’s engagement in India.
• The PSCI Board closed Day 1 with our Annual General Meeting, announcing the newly elected Board members and providing financial and other strategic updates.

Day 2

• Enric Bosch presented an update on projects funded by the PSCI this year, which aim to create impact for suppliers and leverage our collective voice and scale. We also heard from Olivia Li on the recently approved Worker Voice project.
• Ryan Wang from Wuxi Biologics, introduced their recent Green CRDMO Whitepaper.
• Deirdre O’Reilly, Ranjana Ganguly, Germano D’Arasmo, Vijaya Kumar, Sarah Jones and Matthew Thomas of the Health & Safety Topic Team spoke on the critical importance of Health & Safety in the supply chain and the PSCI’s approach on reducing and mitigating critical incidents.
• Birgit Skuballa and Dorota Wiacek presented the latest Audit Findings Analysis Report, our annual analysis of PSCI audits on the platform that highlight key findings, regional differences, and insights within the supply chain.
• Warren Bird and Wenjia Xu then joined Birgit Skuballa and Dorota Wiacek to explore how tools like AI and others can support capability building, linking audit findings directly to PSCI resources.
• Devin Carsdale, Bridget Ferrari, Sandra Matamoros, Diana Killian, and Lucy Latham shared the successes of the PSCI’s first Decarbonization Summit and plans for what comes next.
• Rob Williams and Deidre O’Reilly closed the day reflecting on the PSCI’s partnerships for impact with groups like the CPHI Sustainability Collective and Sustainable Markets Initiative, and discussed how the PSCI should grow its Member and Supplier Partner base in China and Asia more broadly.